Comparison of enzymatic-and bisulfite conversion to map the plasma cell-free methylome in cancer
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Oncology"
DOI: 10.1093/annonc/mdz238.045
Abstract: Abstract Background Aberrant methylation is pervasive in cancer and a promising source of diagnostic and predictive biomarkers. Bisulfite conversion, the current standard for detecting methylated cytosines, requires higher DNA input requirements due to destruction of… read more here.
Keywords: bio inc; lexent; full part; lexent bio ... See more keywords